G. Bouilhol

Honeywell (France)

Papers

1

Total Citations

41

H-Index

1

About

Dr. G. Bouilhol is a leading figure in radiation oncology, whose work has significantly advanced the precision and safety of stereotactic body radiation therapy (SBRT). His primary research focuses on the technical implementation and clinical validation of fiducial marker tracking for real-time tumor targeting, particularly using the CyberKnife® robotic system. Dr. Bouilhol’s major contribution lies in demonstrating the feasibility, efficacy, and low toxicity of fiducial marker implantation for extracranial SBRT, a technique that dramatically improves treatment accuracy for moving tumors. His pivotal 2019 study, which has garnered 41 citations, provides critical evidence that this approach is both safe and effective, offering a robust framework for clinical practice. By systematically evaluating patient outcomes and procedural risks, his work has helped establish fiducial tracking as a standard component of modern, high-precision radiotherapy. Dr. Bouilhol’s research is essential reading for clinicians and physicists seeking to optimize motion management in SBRT, cementing his reputation as a key contributor to the field’s technological evolution.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
41 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Honeywell (France)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago